<?xml version="1.0" encoding="utf-8"?>
<doi_batch xmlns="http://www.crossref.org/schema/4.3.6" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1" xmlns:ai="http://www.crossref.org/AccessIndicators.xsd" xmlns:fr="http://www.crossref.org/fundref.xsd" version="4.3.6" xsi:schemaLocation="http://www.crossref.org/schema/4.3.6 https://www.crossref.org/schemas/crossref4.3.6.xsd">
  <head>
    <doi_batch_id>_1768458106</doi_batch_id>
    <timestamp>20260115062146000</timestamp>
    <depositor>
      <depositor_name>Editor</depositor_name>
      <email_address>editor.jddt@gmail.com</email_address>
    </depositor>
    <registrant>Universal Journal of Pharmaceutical Research</registrant>
  </head>
  <body>
    <journal>
      <journal_metadata>
        <full_title>Universal Journal of Pharmaceutical Research</full_title>
        <abbrev_title>Univ J Pharm Res</abbrev_title>
        <issn media_type="electronic">2456-8058</issn>
        <issn media_type="print">2831-5235</issn>
      </journal_metadata>
      <journal_issue>
        <publication_date media_type="online">
          <month>01</month>
          <day>15</day>
          <year>2026</year>
        </publication_date>
      </journal_issue>
      <journal_article xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1" xmlns:ai="http://www.crossref.org/AccessIndicators.xsd" publication_type="full_text" metadata_distribution_opts="any">
        <titles>
          <title>OBESITY AND THE CLOTTING CASCADE: MECHANISTIC INSIGHTS INTO HAEMOSTATIC ALTERATIONS </title>
        </titles>
        <contributors>
          <person_name contributor_role="author" sequence="first">
            <surname>Ibrahim Kalle Kwaifa</surname>
          </person_name>
          <person_name contributor_role="author" sequence="additional">
            <surname>Emmanuel Ifeanyi Obeagu</surname>
          </person_name>
        </contributors>
        <jats:abstract xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1">
          <jats:p>Obesity is linked to the disruption of haemostasis. Numerous studies have indicated that obese individuals exhibit higher plasma concentrations of all pro-thrombotic factors, such as fibrinogen, von Willebrand factor, and factor VII in comparison to non-obese individuals. Additionally, elevated plasma levels of plasminogen activator inhibitor-1 have been studied in obese individuals compared to non-obese individuals. Moreover, obesity is marked by heightened plasma concentrations of anti-thrombotic agents, such as urokinase plasminogen activator, tissue-type plasminogen activator, and proteins C and S. The rise in these agents may be seen as protective measures to mitigate the impacts of the increased pro-thrombotic factors. The molecular connections between coagulation and fibrinolytic systems facilitate the targeted and efficient breakdown of fibrin accumulations, ensuring continuous blood flow and minimizing blood loss. The link between obesity, endothelial dysfunction, and haemostasis suggests that obesity features elevated levels of von Willebrand factor, fibrinogen, tissue factors, factor VII, VIII, and FX, which have been noted to promote a hypercoagulable condition. Although the coagulation and fibrinolytic systems collaborate to maintain the haemostatic equilibrium of the system, the fibrinolytic system functions to orchestrate the interactions among activators, zymogens, enzymes, cofactors, receptors, and inhibitors of fibrinolysis, facilitating the breakdown of fibrin deposits at the injury site without causing systemic negative effects. Thrombosis linked to obesity is one of the leading global health issues, and thus, continuous updates in this field are essential for improved comprehension of this treatable yet widespread condition.
                  
Peer Review History: 
Received 25 September 2025;   Reviewed 3 November 2025; Accepted  18 December; Available online 15 January 2026
Academic Editor: Dr. Iman Muhammad Higazy, National Research Center, Egypt, imane.higazy@hotmail.com
Reviewers:
Dr. Sabah Hussien El-Ghaiesh, Tanta University, Egypt, s.ghaiesh@gmail.com
Dr. Rawaa Souhil Al-Kayali, Aleppo University, Syria, rawah67@hotmail.com</jats:p>
        </jats:abstract>
        <publication_date media_type="online">
          <month>01</month>
          <day>15</day>
          <year>2026</year>
        </publication_date>
        <fr:program name="fundref"/>
        <ai:program xmlns:ai="http://www.crossref.org/AccessIndicators.xsd" name="AccessIndicators">
          <ai:license_ref>http://creativecommons.org/licenses/by-nc/4.0</ai:license_ref>
        </ai:program>
        <doi_data>
          <doi>10.22270/ujpr.v10i6.1463</doi>
          <resource>https://ujpronline.com/index.php/journal/article/view/1463</resource>
          <collection property="crawler-based">
            <item crawler="iParadigms">
              <resource>https://ujpronline.com/index.php/journal/article/download/1463/2046</resource>
            </item>
          </collection>
          <collection property="text-mining">
            <item>
              <resource mime_type="application/pdf">https://ujpronline.com/index.php/journal/article/download/1463/2046</resource>
            </item>
            <item>
              <resource mime_type="text/xml">https://ujpronline.com/index.php/journal/article/download/1463/2047</resource>
            </item>
            <item>
              <resource mime_type="text/html">https://ujpronline.com/index.php/journal/article/download/1463/2067</resource>
            </item>
          </collection>
        </doi_data>
      </journal_article>
    </journal>
  </body>
</doi_batch>
